{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:31:09Z","timestamp":1793766669812,"version":"4.6.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.xcrm.2024.101484","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T10:30:57Z","timestamp":1711708257000},"page":"101484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma"],"prefix":"10.1016","volume":"5","author":[{"given":"Nguyet-Minh","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa R.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica F.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorv","family":"Kondapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Selberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu N.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Skala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Capitini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-8937","authenticated-orcid":false,"given":"Lixin","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101484_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.xcrm.2024.101484_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","article-title":"Molecular Pathogenesis of Mantle Cell Lymphoma","volume":"34","author":"Navarro","year":"2020","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.xcrm.2024.101484_bib3","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101484_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib6","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1038\/onc.2016.155","article-title":"FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101484_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)33108-2","article-title":"Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial","volume":"391","author":"Wang","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101484_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3324\/haematol.2017.184325","article-title":"A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial","volume":"103","author":"Bomben","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2024.101484_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","article-title":"Targeting pathological B cell receptor signalling in lymphoid malignancies","volume":"12","author":"Young","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2024.101484_bib10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","article-title":"Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes","volume":"26","author":"Cheah","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2024.101484_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/leu.2014.263","article-title":"Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors","volume":"29","author":"Cheng","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101484_bib12","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Woyach","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau1167","article-title":"Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma","volume":"11","author":"Zhang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","article-title":"Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage","volume":"30","author":"Queir\u00f3s","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","article-title":"The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers","volume":"25","author":"Russler-Germain","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib16","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1073\/pnas.1703476114","article-title":"Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement","volume":"114","author":"Dai","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib17","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jgg.2020.04.006","article-title":"DNA methyltransferases in hematological malignancies","volume":"47","author":"Hoang","year":"2020","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.xcrm.2024.101484_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030320","article-title":"DNMT3A in Leukemia","volume":"7","author":"Brunetti","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib22","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib23","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib24","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/bloodadvances.2019001350","article-title":"Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis","volume":"4","author":"Hill","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2024.101484_bib25","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41375-019-0489-6","article-title":"PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K\/AKT in lymphoma cells","volume":"33","author":"Zhu","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101484_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/1541-7786.MCR-21-0267","article-title":"EGR1 Addiction in Diffuse Large B-cell Lymphoma","volume":"19","author":"Kimpara","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib27","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","article-title":"Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101484_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001798","article-title":"Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in\u00a0vivo","volume":"3","author":"Kim","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101484_bib29","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014225","article-title":"MYC and mitochondrial biogenesis","volume":"4","author":"Morrish","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib30","doi-asserted-by":"crossref","first-page":"a014217","DOI":"10.1101\/cshperspect.a014217","article-title":"MYC, metabolism, cell growth, and tumorigenesis","volume":"3","author":"Dang","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib31","doi-asserted-by":"crossref","first-page":"36267","DOI":"10.1074\/jbc.M110.141606","article-title":"Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry","volume":"285","author":"Morrish","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101484_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI74942","article-title":"PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis","volume":"125","author":"Bueno","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101484_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13067","article-title":"Mitochondrial mass governs the extent of human T\u00a0cell senescence","volume":"19","author":"Callender","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature25477","article-title":"Structural basis for DNMT3A-mediated de novo DNA methylation","volume":"554","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101484_bib35","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI97924","article-title":"DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine","volume":"128","author":"Yu","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101484_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.stem.2016.06.020","article-title":"Dnmt3a and Dnmt3b Associate with Enhancers to Regulate Human Epidermal Stem Cell Homeostasis","volume":"19","author":"Rinaldi","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1534-3","article-title":"The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape","volume":"573","author":"Weinberg","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101484_bib38","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1038\/ncomms8953","article-title":"MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation","volume":"6","author":"Pon","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101484_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccell.2018.08.006","article-title":"MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis","volume":"34","author":"Brescia","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib40","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2024.101484_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1534-3","article-title":"The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape","volume":"573","author":"Weinberg","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101484_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nbt.1563","article-title":"Genome-wide identification of post-translational modulators of transcription factor activity in human B cells","volume":"27","author":"Wang","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101484_bib43","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1111\/jcmm.13916","article-title":"MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer","volume":"22","author":"Pang","year":"2018","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7600509","article-title":"Myc represses transcription through recruitment of DNA methyltransferase corepressor","volume":"24","author":"Brenner","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2024.101484_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ng0398-231","article-title":"Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice","volume":"18","author":"Larsson","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2024.101484_bib46","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.008367","article-title":"MEF2: a central regulator of diverse developmental programs","volume":"134","author":"Potthoff","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.xcrm.2024.101484_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101484_bib48","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2024.101484_bib50","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JBO.25.7.071203","article-title":"Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications","volume":"25","author":"Datta","year":"2020","journal-title":"J.\u00a0Biomed. Opt."},{"key":"10.1016\/j.xcrm.2024.101484_bib53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1562\/2005-11-23-RA-738","article-title":"Riboflavin as a source of autofluorescence in Eisenia fetida coelomocytes","volume":"82","author":"Koziol","year":"2006","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.xcrm.2024.101484_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.neo.7900077","article-title":"Fluorescence spectroscopy of neoplastic and non-neoplastic tissues","volume":"2","author":"Ramanujam","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.xcrm.2024.101484_bib55","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1016\/S0021-9258(19)70779-0","article-title":"Picosecond fluorescence lifetime of the coenzyme of D-amino acid oxidase","volume":"255","author":"Nakashima","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101484_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41551-020-0592-z","article-title":"Classification of T-cell activation via autofluorescence lifetime imaging","volume":"5","author":"Walsh","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2024.101484_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2018-05-851667","article-title":"Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma","volume":"133","author":"Mohanty","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cncr.11543","article-title":"Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia","volume":"98","author":"Kantarjian","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101484_bib59","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2005.11.981","article-title":"Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate","volume":"23","author":"Issa","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101484_bib60","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/ajh.25939","article-title":"Phase I\/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia","volume":"95","author":"Abaza","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.xcrm.2024.101484_bib61","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21792","article-title":"Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101484_bib62","first-page":"53","article-title":"Decitabine in the treatment of acute myeloid leukemia in elderly patients","volume":"6","author":"Malik","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/leu.2015.244","article-title":"A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"30","author":"Daver","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101484_bib64","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hon.2663","article-title":"Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy","volume":"37","author":"Bocchia","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2024.101484_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.leukres.2018.11.015","article-title":"Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience","volume":"76","author":"Fil\u00ec","year":"2019","journal-title":"Leuk. Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib66","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/cas.13482","article-title":"New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor\/AKT\/mammalian target of rapamycin pathways","volume":"109","author":"Lam","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.xcrm.2024.101484_bib67","article-title":"Repression of LKB1 by miR-17 approximately 92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment","volume":"1","author":"Izreig","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101484_bib68","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10637-022-01277-9","article-title":"First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors","volume":"40","author":"Janku","year":"2022","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.xcrm.2024.101484_bib69","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1158\/1078-0432.CCR-10-1818","article-title":"Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer","volume":"16","author":"Kang","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib70","doi-asserted-by":"crossref","first-page":"106233","DOI":"10.18632\/oncotarget.22287","article-title":"Mitochondrial targeted HSP90 inhibitor Gamitrinib-TPP (G-TPP) induces PINK1\/Parkin-dependent mitophagy","volume":"8","author":"Fiesel","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2024.101484_bib71","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI44855","article-title":"Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells","volume":"121","author":"Siegelin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101484_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2007.08.028","article-title":"Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network","volume":"131","author":"Kang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib73","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI37613","article-title":"Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90","volume":"119","author":"Kang","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101484_bib74","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib75","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.2023020142","article-title":"EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma","volume":"142","author":"Liu","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/ejh.12030","article-title":"Clonal heterogeneity of mantle cell lymphoma revealed by array comparative genomic hybridization","volume":"90","author":"Liu","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.xcrm.2024.101484_bib77","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood-2012-04-421065","article-title":"Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis","volume":"121","author":"Vasanthakumar","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006334","article-title":"Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma","volume":"12","author":"Haney","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.xcrm.2024.101484_bib79","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","article-title":"Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia","volume":"36","author":"Baccelli","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"De Cecco","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101484_bib81","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016289118","article-title":"Noncanonical immune response to the inhibition of DNA methylation by Staufen1 via stabilization of endogenous retrovirus RNAs","volume":"118","author":"Ku","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib82","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101484_bib84","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.1612262113","article-title":"Vitamin C increases viral mimicry induced by 5-aza-2\u2032-deoxycytidine","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib85","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.18632\/oncotarget.1821","article-title":"The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma","volume":"5","author":"Maes","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2024.101484_bib86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.biopha.2013.01.004","article-title":"Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2\/M phase through p53-independent pathway in human cancer cells","volume":"67","author":"Shin","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2024.101484_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2022-163018","article-title":"Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network","volume":"140","author":"Dreyling","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood-2022-158656","article-title":"Phase 2 Trial of Acalabrutinib-Lenalidomide-Rituximab (ALR) with Real-Time Monitoring of MRD in Patients with Treatment-Na\u00efve Mantle Cell Lymphoma","volume":"140","author":"Ruan","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101484_bib89","doi-asserted-by":"crossref","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","article-title":"New developments on the Encyclopedia of DNA Elements (ENCODE) data portal","volume":"48","author":"Luo","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib90","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.celrep.2017.09.066","article-title":"A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas","volume":"21","author":"Ryan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101484_bib91","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1038\/s41467-019-12494-x","article-title":"Genetic modification of primary human B cells to model high-grade lymphoma","volume":"10","author":"Caeser","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101484_bib92","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jcb.20447","article-title":"Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family","volume":"95","author":"Chen","year":"2005","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.xcrm.2024.101484_bib93","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M513249200","article-title":"The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells","volume":"281","author":"Li","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101484_bib94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101484_bib95","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2024.101484_bib96","author":"Gaspar"},{"key":"10.1016\/j.xcrm.2024.101484_bib97","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2024.101484_bib98","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1002\/cpz1.585","article-title":"Exploring Epigenomic Datasets by ChIPseeker","volume":"2","author":"Wang","year":"2022","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.xcrm.2024.101484_bib99","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","article-title":"ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2024.101484_bib100","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/nar\/gks001","article-title":"Summarizing and correcting the GC content bias in high-throughput sequencing","volume":"40","author":"Benjamini","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib101","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","article-title":"Cellpose 2.0: how to train your own model","volume":"19","author":"Pachitariu","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2024.101484_bib102","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2024.101484_bib103","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ng.3258","article-title":"Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells","volume":"47","author":"Liao","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2024.101484_bib104","doi-asserted-by":"crossref","first-page":"E7260","DOI":"10.1073\/pnas.1610970113","article-title":"Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma","volume":"113","author":"Rui","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib105","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101484_bib107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/1-59259-973-7:073","article-title":"Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage","volume":"314","author":"Huang","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2024.101484_bib108","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.17.11.116015","article-title":"Ex\u00a0vivo optical metabolic measurements from cultured tissue reflect in\u00a0vivo tissue status","volume":"17","author":"Walsh","year":"2012","journal-title":"J.\u00a0Biomed. Opt."},{"key":"10.1016\/j.xcrm.2024.101484_bib109","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1073\/pnas.89.4.1271","article-title":"Fluorescence lifetime imaging of free and protein-bound NADH","volume":"89","author":"Lakowicz","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-bioeng-071811-150108","article-title":"Optical imaging using endogenous contrast to assess metabolic state","volume":"14","author":"Georgakoudi","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2024.101484_bib111","doi-asserted-by":"crossref","first-page":"19494","DOI":"10.1073\/pnas.0708425104","article-title":"In\u00a0vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia","volume":"104","author":"Skala","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101484_bib112","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1016\/S0021-9258(17)30079-0","article-title":"Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals","volume":"254","author":"Chance","year":"1979","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124001307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124001307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T23:58:51Z","timestamp":1714348731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666379124001307"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101484","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101484"}}